2007
DOI: 10.1097/mat.0b013e31812e6a90
|View full text |Cite
|
Sign up to set email alerts
|

Noninvasive Measurement of Cardiac Output in Hemodialysis Patients by Task Force Monitor: A Comparison with the Transonic System

Abstract: Cardiovascular disease is the leading cause of morbidity and mortality in maintenance hemodialysis (MHD) patients. The Transonic (TRS; Transonic Systems, Ithaca, NY) device is frequently used for determination of cardiac output (CO) by an indicator dilution technique. The Task Force Monitor (TFM; CN Systems, Graz, Austria) has gained attention as noninvasive tool for continuous beat-to-beat assessment of cardiovascular variables, including CO by impedance cardiography. Despite its use in cardiology and intensi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
1
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(18 citation statements)
references
References 25 publications
0
16
1
1
Order By: Relevance
“…Among noninvasive techniques, thoracic bioimpedance cardiography (ICG) is an attractive operator-independent and cost-effective method. ICG was developed by the National Aeronautics and Space Administration in the 1960s to monitor cardiac output in astronauts (13), and this approach has been used in critically ill patients (14,15) and in patients with heart failure (16). The ICG signal is obtained from thoracic impedance detected at beat-to-beat intervals; changes in thorax impedance during the cardiac cycle allow for the calculation of stroke volume, cardiac output, and indicators of cardiac contractility (17).…”
Section: Introductionmentioning
confidence: 99%
“…Among noninvasive techniques, thoracic bioimpedance cardiography (ICG) is an attractive operator-independent and cost-effective method. ICG was developed by the National Aeronautics and Space Administration in the 1960s to monitor cardiac output in astronauts (13), and this approach has been used in critically ill patients (14,15) and in patients with heart failure (16). The ICG signal is obtained from thoracic impedance detected at beat-to-beat intervals; changes in thorax impedance during the cardiac cycle allow for the calculation of stroke volume, cardiac output, and indicators of cardiac contractility (17).…”
Section: Introductionmentioning
confidence: 99%
“…However, our study was not planned as a validation study; rather, we aimed to demonstrate the applicability of ICG-derived hemodynamic measurements in cirrhotic patients. The TFM and other commercially available devices equipped with ICG to define hemodynamic status were already utilized in previous researches where ICG results were confirmed and validated in comparison with invasive and noninvasive methods (4,6,7,(12)(13)(14)(15)17). Therefore, we did not need to involve any invasive or noninvasive comparative hemodynamic assessment tool.…”
Section: Discussionmentioning
confidence: 99%
“…From this point of view, TFM, which has already obtained FDA 510(k) (K014063) clearance, is a novel noninvasive hemodynamic monitoring tool utilizing an improved estimate of thoracic volume (considering the influence of the patient's body weight on the thorax shape, a mathematical model based on a "modified" Kubicek and Sramek designs is applied) and new shortband electrodes to generate a good homogeneous thoracic field (6). Previous reports have proven the applicability of TFM in various clinical conditions, including hemodynamic monitoring in heart transplant candidates in comparison with both thermodilution and another commercially available ICG device (6) and in hemodialysis patients (17), and its utility for optimization of cardiac resynchronization therapy (18) and for evaluation of exercise physiology (19,20) and vasovagal syncope (21). However, there are only a few reports (with very small sample sizes) involving ICG as a noninvasive measure of hemodynamics in cirrhosis patients (4,8).…”
Section: Discussionmentioning
confidence: 99%
“…Both ScvO 2 and Hgb are indispensable for eU-BBF computation, and the advent of the Crit-Line Monitor has made routine, noninvasive and quasi-continuous measurements of these 2 parameters during HD a reality. Future detailed physiological studies including hemodynamic monitoring [30] and AVF flow measurement are required to better understand the maturation dynamics and the associated hemodynamic adaptation. Efforts should be made to characterize the expected trajectories of ScvO 2 and eUBBF during adequate AVF maturation and cardiac adaptation.…”
Section: Discussionmentioning
confidence: 99%